News | May 25, 2022
Johnson & Johnson and Momenta Pharmaceuticals file lawsuit against NATCO Pharma
This lawsuit has been filed in the Pennsylvania Federal Court. NATCO and its marketing partner Mylan
This lawsuit has been filed in the Pennsylvania Federal Court. NATCO and its marketing partner Mylan
Novel tool bypasses plasmid-based expression to increase stability and significantly reduce development time for a variety of synthetic biotechnology products
The panel is headed by DCGI Dr VG Somani with representatives from various state drug regulators and health ministry
The ruling comes against the backdrop of a mounting trauma burden in India, where nearly 4.67 lakh accidental deaths occur annually
The ruling brings closure to a nearly decade-long investigation into hospital operations and healthcare delivery practices
US federal jury finds Japanese drugmaker liable for anticompetitive agreement delaying generic version of constipation drug Amitiza
A high-resolution CT scan with 0.5 mm slices was used to design a customised titanium implant tailored to the patient’s anatomy and bone loss pattern
These check-ups will be conducted through ESIC’s extensive network of hospitals, with a focus on early diagnosis, preventive healthcare, and continuous health monitoring
Company confirms seized products were not from its authorised supply chain and urges patients to purchase medicines only through licensed pharmacies
The deals, tied to cases in the US District Court for the District of Delaware, effectively extend US patent protection for VYNDAMAX until June 1, 2031
Subscribe To Our Newsletter & Stay Updated
